Forte Biosciences Ownership | Who Owns Forte Biosciences?
Forte Biosciences Ownership Summary
Forte Biosciences is owned by 9.17% institutional investors, 2.15% insiders, and 88.68% retail investors. Tybourne capital management (hk) is the largest institutional shareholder, holding 6.70% of FBRX shares. Federated Hermes Kaufmann Growth is the top mutual fund, with 5.08% of its assets in Forte Biosciences shares.
FBRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Forte Biosciences | 9.17% | 2.15% | 88.68% |
| Sector | Healthcare Stocks | 35.74% | 11.83% | 52.43% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Tybourne capital management (hk) | 786.65K | 6.70% | $11.80M |
| Vanguard group | 582.26K | 3.27% | $15.88M |
| Federated hermes | 1.77M | 1.20% | $45.73M |
| Fred alger management | 1.27M | 0.87% | $33.00M |
| Orbimed advisors | 1.20M | 0.81% | $31.00M |
| Janus henderson group | 1.19M | 0.81% | $30.81M |
| Affinity asset advisors | 1.01M | 0.69% | $26.21M |
| Bioimpact capital | 1.00M | 0.68% | $25.92M |
| Adage capital partners gp | 950.00K | 0.65% | $24.61M |
| Bvf inc/il | 65.35K | 0.56% | $980.25K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tybourne capital management (hk) | 786.65K | 38.15% | $11.80M |
| Cable car capital | 400.00K | 3.58% | $10.36M |
| Bioimpact capital | 1.00M | 2.00% | $25.92M |
| Affinity asset advisors | 1.01M | 1.35% | $26.21M |
| Sphera funds management | 184.98K | 0.76% | $4.79M |
| Orbimed advisors | 1.20M | 0.62% | $31.00M |
| Awm investment company | 200.00K | 0.57% | $5.18M |
| Stempoint capital lp | 58.02K | 0.29% | $1.50M |
| Ikarian capital | 118.97K | 0.25% | $3.08M |
| Integral health asset management | 150.00K | 0.19% | $3.88M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | 1.00M | 2.00% | 1.00M |
| Adage capital partners gp | 950.00K | 0.04% | 616.67K |
| Morgan stanley | 500.30K | 0.00% | 429.77K |
| Citadel advisors | 233.37K | 0.00% | 233.37K |
| Integral health asset management | 150.00K | 0.19% | 150.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bml capital management | - | - | -1.76M |
| Bvf inc/il | 65.35K | 0.04% | -522.99K |
| Point72 asset management | - | - | -487.27K |
| Janus henderson group | 1.19M | 0.02% | -237.72K |
| Fred alger management | 1.27M | 0.14% | -187.01K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bioimpact capital | 1.00M | 2.00% | 1.00M | $25.92M |
| Integral health asset management | 150.00K | 0.19% | 150.00K | $3.88M |
| Lord, abbett | 114.64K | 0.01% | 114.64K | $2.97M |
| Russell investments group | 91.77K | 0.00% | 91.77K | $2.38M |
| Candriam s.c.a. | 84.80K | 0.01% | 84.80K | $2.20M |
Sold Out
| Holder | Change |
|---|---|
| Rockefeller capital management | -28.00 |
| Loring wolcott & coolidge fiduciary advisors llp/ma | -193.00 |
| Private trust co na | -274.00 |
| Tower research capital llc (trc) | -773.00 |
| Advisor group | -1.08K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 70 | 16.67% | 13,499,434 | 17.15% | 9 | 0.22% | 39 | -13.33% | 21 | 200.00% |
| Dec 31, 2025 | 19 | -54.76% | 2,710,133 | -73.80% | 15 | 0.20% | 13 | -51.85% | 3 | -40.00% |
| Sep 30, 2025 | 15 | -54.55% | 3,195,999 | -67.42% | 27 | 0.39% | 11 | -52.17% | 1 | -75.00% |
| Jun 30, 2025 | 7 | -75.86% | 1,313,474 | -73.91% | 11 | 0.59% | 5 | -61.54% | - | -100.00% |
| Mar 31, 2025 | 29 | 11.54% | 5,034,503 | 17.74% | 44 | 0.21% | 13 | -13.33% | 4 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Federated Hermes Kaufmann Growth | 1.04M | 5.08% | - |
| Federated Hermes Kaufmann R | 1.04M | 5.08% | - |
| Vanguard Total Stock Mkt Idx Inv | 622.93K | 4.48% | 229.20K |
| Federated Hermes Kaufmann Small Cap Grow | 702.40K | 3.43% | - |
| Federated Hermes Kaufmann Small Cap A | 702.40K | 3.43% | - |
| Alger Small Cap Focus I | 496.06K | 2.42% | - |
| Alger Small Cap Focus Composite | 496.06K | 2.42% | - |
| Biotech Growth Ord | 312.73K | 2.25% | 227.73K |
| Fidelity Select Biotechnology | 340.69K | 1.66% | 29.73K |
| Vanguard Institutional Extnd Mkt Idx Tr | 188.66K | 1.36% | 63.77K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 30, 2025 | Riley Antony A | CHIEF FINANCIAL OFFICER | Buy | $254.83K |
| Nov 21, 2024 | Riley Antony A | CHIEF FINANCIAL OFFICER | Buy | $125.00K |
| Dec 18, 2023 | Wagner Paul A. | See Remarks | Buy | $7.53K |
| Dec 13, 2023 | Wagner Paul A. | See Remarks | Buy | $7.35K |
| Dec 14, 2023 | Wagner Paul A. | See Remarks | Buy | $7.20K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | 1 | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
FBRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools